Recurrent Sarcoma: Clinical Trials

4 trials for Recurrent Sarcoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 completed, 1 recruiting, 1 terminated. 2 Early Phase 1, 2 Not applicable.

By phase and status

PhaseTrialsStatus
Early Phase 12Active not recruiting 1, Terminated 1
Not applicable2Completed 1, Recruiting 1

Follow Recurrent Sarcoma: new trials by email Literature Review of Recurrent Sarcoma trials Research Report on Recurrent Sarcoma

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Recurrent Sarcoma
Doxorubicin, Doxorubicin Hydrochloride, Drug Delivery Microdevice - Metastatic Sarcoma, Recurrent Sarcoma
Not applicableRecruitingM.D. Anderson Cancer Center202025-02-252026-08-11
68Ga-FAPi-46 PET/CT Scan in Imaging Patients With Sarcoma
Computed Tomography, Gallium Ga 68 FAPi-46, Positron Emission Tomography - Metastatic Sarcoma, Recurrent Sarcoma
Early Phase 1Active not recruitingJonsson Comprehensive Cancer Center182020-09-082026-09-17
Heated Intra-peritoneal Chemotherapy With Doxorubicin and Cisplatin for Abdominal for Pelvic Tumors in Pediatric Patients
Cisplatin, Cytoreductive Surgery, Doxorubicin - Malignant Abdominal Neoplasm, Malignant Pelvic Neoplasm
Early Phase 1TerminatedMayo Clinic22019-11-082025-02-20
Radiotherapy With Hyperthermia in Recurrent and Radiation-Induced Sarcomas
Hypofractionated radiotherapy, Hyperthermia, Hypofractionated radiotherapy with boost - Radiation Induced Neoplasms, Radiation-Induced Cancer
Not applicableCompletedMaria Sklodowska-Curie National Research Institute of Oncology202019-10-232025-04-30

Narrower conditions

Sarcoma (4)  ·  Colonic Neoplasms (1)  ·  Desmoplastic Small Round Cell Tumor (1)  ·  Fallopian Tube Neoplasms (1)  ·  Liposarcoma (1)  ·  Mesothelioma, Malignant (1)  ·  Neoplasms, Radiation-Induced (1)  ·  Ovarian Neoplasms (1)  ·  Pelvic Neoplasms (1)  ·  Rectal Neoplasms (1)  ·  Rhabdomyosarcoma (1)  ·  Stomach Neoplasms (1)

Broader conditions

Neoplasms (4)  ·  Neoplasms by Histologic Type (4)  ·  Neoplasms, Connective and Soft Tissue (4)  ·  Adenoma (1)  ·  Adnexal Diseases (1)  ·  Colonic Diseases (1)  ·  Colorectal Neoplasms (1)  ·  Digestive System Diseases (1)  ·  Digestive System Neoplasms (1)  ·  Endocrine Gland Neoplasms (1)  ·  Endocrine System Diseases (1)  ·  Fallopian Tube Diseases (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Gastrointestinal Diseases (1)

Interventions

Doxorubicin (2)  ·  Magnetic Resonance Spectroscopy (2)  ·  1,2-diaminocyclohexaneplatinum II citrate (1)  ·  Cisplatin (1)  ·  Cytoreduction Surgical Procedures (1)  ·  Diathermy (1)  ·  Everolimus (1)  ·  FAPI-46 (1)  ·  Fluorodeoxyglucose F18 (1)  ·  Hyperthermic Intraperitoneal Chemotherapy (1)  ·  Ifosfamide (1)  ·  Irinotecan (1)  ·  Platinum (1)  ·  Polyethylene Glycols (1)  ·  Radiation Dose Hypofractionation (1)

Sponsors

Jonsson Comprehensive Cancer Center (1)  ·  M.D. Anderson Cancer Center (1)  ·  Maria Sklodowska-Curie National Research Institute of Oncology (1)  ·  Mayo Clinic (1)

Countries

United States (3)  ·  Poland (1)

Top investigators

Jeremie Calais, MD (1)  ·  Joseph Ludwig, MD (1)  ·  Patricio C. Gargollo, M.D. (1)

NIH funding

R01CA180279 (1)